SEER Inquiry System - View
| Print Question |
| Question: 20120056 |
|---|
|
Status Final References Source 1: SEER*Rx pgs: Notes: Source 2: pgs: Notes: Question First course treatment--Corpus Uteri: Should Arimidex be coded as hormone therapy for an endometrioid adenocarcinoma? See discussion. Discussion Per the SEER Manual, endometrial cancers may be treated with progesterone which is coded as hormone therapy for these primaries. As endometrioid adenocarcinomas are hormonally-dependent carcinomas, should an aromatase inhibitor or anti-estrogen agent also be coded as hormone therapy? Answer Arimidex has not been approved to treat endometrial cancer. It is not prescribed for pre-menopausal women. Please clarify the reason the drug was being given with the physician. If the physician states Arimidex was given to reduce tumor burden, code as hormone therapy. See the SEER*Rx interactive database, http://www.seer.cancer.gov/seertools/seerrx/ History Last Updated 09/11/2012 Date Finalized 09/11/2012 |